D-1016-2017 Class II Terminated

Recalled by SCA Pharmaceuticals — Little Rock, AR

Recall Details

Product Type
Drugs
Report Date
August 2, 2017
Initiation Date
July 14, 2017
Termination Date
May 1, 2019
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
N/A

Product Description

fentaNYL 3 mcg/mL + BUPIvacaine 0.1% in 0.9% Sodium Chloride 250 mL, Rx only, SCA Pharmaceuticals 8821 Knoedl Ct Little Rock, AR 72205 --- NDC# 70004-0290-40

Reason for Recall

Lack of Assurance of Sterility; product has the potential to leak.

Distribution Pattern

Nationwide

Code Information

Lot: 20170506@27 BUD: 8/4/2017